Hirneiss C, Neubauer A S, Welge-Lüssen U, Eibl K, Kampik A
Augenklinik der Ludwig-Maximilians-Universität, München.
Ophthalmologe. 2003 Dec;100(12):1091-7. doi: 10.1007/s00347-003-0884-1.
The assessment of patient's quality of life is not only of vital importance for clinical trials of new therapies but also becomes more and more implemented into daily clinical therapeutical decisions.
Different methods for evaluating quality of life are available. A well-known questionnaire for measuring global quality of life is the Short Form 36 (SF 36). However, in ophthalmology more specific instruments for measuring visual quality of life are needed. We review the usefulness of specific questionnaires such as the Visual Function 14 (VF-14) or the National Eye Institute Visual Function Questionnaire (NEI-VFQ) in their application to common ophthalmologic diseases such as cataract, age-related macular degeneration and glaucoma. Studies applying these methods were identified by a search in the Medline database.
Several instruments to measure visual life quality in ophthalmologic patients are available. Internal consistency and validity are shown.
Evaluating visual quality of life is an important parameter for assessing ophthalmologic diseases and the value of different therapies. It is an important outcome variable in clinical studies. Furthermore, individual visual quality of life should be considered in individual therapeutic decisions and helps to assess the economic effect of current and new therapies.
患者生活质量的评估不仅对新疗法的临床试验至关重要,而且越来越多地应用于日常临床治疗决策中。
有多种评估生活质量的方法。一种广为人知的用于测量总体生活质量的问卷是简短健康调查问卷36项版(SF-36)。然而,在眼科领域,需要更具针对性的工具来测量视觉生活质量。我们回顾了诸如视觉功能14项问卷(VF-14)或美国国立眼科研究所视觉功能问卷(NEI-VFQ)等特定问卷在白内障、年龄相关性黄斑变性和青光眼等常见眼科疾病中的应用价值。通过检索Medline数据库确定了应用这些方法的研究。
有几种用于测量眼科患者视觉生活质量的工具。这些工具显示出了内部一致性和有效性。
评估视觉生活质量是评估眼科疾病及不同疗法价值的重要参数。它是临床研究中的一个重要结局变量。此外,在个体治疗决策中应考虑个体的视觉生活质量,这有助于评估现有疗法和新疗法的经济效益。